BOJHT
VKTX icon

Bank of Jackson Hole Trust’s Viking Therapeutics VKTX Stock Holding History

Bank of Jackson Hole Trust’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.51K Hold
200
– – ﹤0.01% 425
2025
Q4 		$7.04K Buy
+200
New +$7.09K ﹤0.01% 419

Other funds holding VKTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bank of Jackson Hole Trust's VKTX Position: Q1 2026 in Review

Bank of Jackson Hole Trust held its Viking Therapeutics (VKTX) position steady in Q1 2026 at 200 shares worth $6.51K. The position accounts for ﹤0.01% of the portfolio, ranked #425.

Bank of Jackson Hole Trust first reported a position in VKTX in Q4 2025 and has held it in 2 quarters since. The position peaked at $7.04K in Q4 2025. 410 funds tracked by Wall St. Rank hold VKTX as of Q1 2026.

  • Bank of Jackson Hole Trust held 200 shares of Viking Therapeutics worth $6.51K as of Q1 2026.
  • Bank of Jackson Hole Trust left its Viking Therapeutics share count unchanged in Q1 2026.
  • Viking Therapeutics made up ﹤0.01% of Bank of Jackson Hole Trust's portfolio in Q1 2026, its #425 holding.
  • Bank of Jackson Hole Trust first reported a position in Viking Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Bank of Jackson Hole Trust's Viking Therapeutics position peaked at $7.04K in Q4 2025.
  • 410 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2026.

Based on Bank of Jackson Hole Trust's 13F filing for Q1 2026, filed 12 May 2026.